Clinical Development Scientist, Companion Animal Health
ElancoClinical Development Scientist, Companion Animal Health
ElancoLocation
Indianapolis, IN
Type
Full-time
Posted
10/15/2026
Compensation
Not listed
Job description
The Clinical Development Scientist at Elanco will play a crucial role in delivering innovative vaccines and therapeutic products for companion animals. This position involves leading clinical studies from design to regulatory approval, ensuring compliance with global standards. The scientist will collaborate with cross-functional teams to advance animal well-being and support Elanco's mission. This role is pivotal in driving the clinical program strategy and fostering innovation within the company.
Requirements
- A DVM or Ph.D. in a relevant scientific discipline; OR an M.S. in a relevant discipline.
- A minimum of 5 years of direct experience in veterinary product development for candidates with an M.S. degree.
- Proven experience in the clinical development of health products, including hands-on involvement in planning and executing studies.
- Strong collaboration and communication skills to effectively drive projects in a cross-functional, team-oriented environment.
Responsibilities
- Lead the planning, implementation, and reporting of high-quality clinical studies for new companion animal vaccines and therapeutics.
- Author comprehensive study protocols and final reports, select and manage contract research facilities, and oversee all aspects of study execution.
- Develop and execute strategic clinical development plans in collaboration with cross-functional teams.
- Partner with Regulatory Affairs to prepare and present clinical data for submission to global regulatory agencies.
- Drive quality and compliance within clinical programs and contribute to process improvements.
Benefits
- Employees at Elanco are often offered competitive compensation with annual bonus and equity eligibility, retirement plans (including a U.S. 401(k)), and comprehensive health coverage—medical, dental, vision, company-paid life and disability—and even pet insurance. Time-off and flexibility typically include generous PTO, U.S. mid-year and year-end paid shutdown weeks, parental leave, and flexible/remote work options. Employees also benefit from strong development programs (onboarding, course libraries, mentorship, nine ERGs, and tiered leadership programs) that support both professional growth and community involvement.
H-1B filing history
Public USCIS petition and DOL LCA counts · latest USCIS FY2026, LCA FY2026
Combined across 2 filing entities: Elanco Us Inc, Elanco Animal Health Inc
As of Aug 23, 2026
Initial approvals
4
FY2026
Approval rate
100.0%
FY2026
LCA certified
12
FY2026
Entry-level share
0.0%
FY2026
Initial approvals YoY
+3%
Trend
LCA certified YoY
-25%
Trend
Initial approvals by fiscal year
Approval rate by fiscal year
Continuing vs initial approvals
LCA certified positions by quarter
LCA certified positions by fiscal year
Based on public USCIS and DOL filings; not a sponsorship guarantee.
Is this posting expired or inaccurate?
